Richtlijn CVRM feb2013 - KNMP

Schrader 2005
Schulman 2009
SEARCH 2010
Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, et al. Morbidity and mortality
after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a
prospective randomized controlled study (MOSES). Stroke. 2005;36:1218-26.
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H,et al. Dabigatran versus
warfarin in the treatment of acute venous thromboembolism N Engl J Med. 2009;
361(24):2342-52.
SEARCH Collaborative Group, Armitage IM et al. Effects of homocysteïne-lowering with folic acid plus
vitamin B12 vs placebo on mortality and morbidity in myocardial infarction survivors. A randomized
trial. JAMA 2010; 303: 2486-2494.
Seelen 1996 Seelen MAJ, Meijer PHEM, Braun J, Swinkels LMJW, Waanders H en Meinders AE. Hypertensie
door dropgebruik. NTvG 1996; 140: 2632-2635.
Serebruany 2005 Serebruany VL, Steinhulb SR, Berger PB, et al. Variability in platelet respinsiveness to
clopidogrel among 544 individuals. J Am Coll Cardiol. 2005; 45: 246-51.
Seshasai 2012 Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, et al. Effect of
aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.
Inter Med 2012; 172 (3): 209-16.
Arch
Shepherd 2002
Silber 2005
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM. Et al. Pravastatin in elderly
individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002; 360:
1623-1630.
Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Task force for percutaneous
coronary interventions of the european society of cardiology. Guidelines for percutaneous coronary
interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of
Cardiology. Eur Heart J 2005; 26: 804-47.
Silva 2007 Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, et al. Meta-analysis of drug
induced adverse events associated with intensive-dose statin therapy. Clin Ther 2007; 29: 253-
60.
Simons 2011 Simons LA, Ortiz M, Calcino G Long term persistence with statin therapy -- experience in
Australia 2006-2010. Aust Fam Physician. 2011 May;40(5):319-22.
Simpson 2010 Simpson RJ Jr, Mendys P. The effects of adherence and persistence on clinical outcomes in
patients treated with statins: a systematic review. J Clin Lipidol. 2010;4(6):462-71.
Singh 2011 Singh PP, Singh M, Bedi U, Molnar J, Arora R, Khosla S. Safety and efficacy of triple
antithrombotic therapy afater percutaneous coronary intervention in patients needing longanti
coagulation. Ther Adv Cardiovasc Dis 2011; 5 (1): 23-31.
term
Sipahi 2007
Slagman 2011
Sipahi I, Tuzcu EM, Wolski KE, Nicholls SJ, Schoenhagen P, Hu B, et al. ß-Blockers and progression of
coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann Intern Med
2007; 147: 10-18.
Slagman MC, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme
inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised
controlled trial. BMJ 2011; 343: d4366.
SmPC Pradaxa SmPC pradaxa ®. http://www.cbg-meb.nl/CBG/nl/humane-geneesmiddelen
/actueel/Nieuwe__contra-indicatie_Pradaxa/default.htm. 04-01-2013.
SPC Crestor
( Dutch) SPC Crestor®. http://www.cbg-meb.nl/nl/prodinfo/index.htm.25-02-2005
SPC Lescol ( Dutch) SPC Lescol®.http://www.cbg-meb.nl/nl/prodinfo/index.htm. 30-01-2004
SPC Lipitor
SPC Selektine
( Dutch) SPC Lipitor®. http://www.cbg-meb.nl/nl/prodinfo/index.htm.07-12-2004
( Dutch) SPC Selektine®. http://www.cbg-meb.nl/nl/prodinfo/index.htm.16-12-2005
SPC Zocor ( Dutch) SPC Zocor®. http://www.cbg-meb.nl/nl/prodinfo/index.htm. 5-1-2005.
98
CONCEPT